Sectoral Asset Management »

Transmedics Group shares owned by Sectoral Asset Management

Quarter-by-quarter ownership of Transmedics Group (TMDX) shares owned by Sectoral Asset Management from 13F filings

Historical chart of Sectoral Asset Management investment in Transmedics Group

Tip: Access up to 7 years of quarterly data

All positions including Transmedics Group held by Sectoral Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Transmedics Group by Sectoral Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.5M 22k 66.42

More positions owned by Sectoral Asset Management

Contineum Therapeutics Cl A (CTNM)
Shoulder Innovations Common Stock (SI)
Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Johnson & Johnson (JNJ)
Oruka Therapeutics (ORKA)
Biontech Se Sp Adr (BNTX)
Definium Therapeutics Com Shs (DFTX)
Dex (DXCM)
Arcus Biosciences Incorporated (RCUS)
Amgen (AMGN)
Summit Therapeutics (SMMT)
Irhythm Technologies (IRTC)
Abbvie (ABBV)
Merck & Co (MRK)

View all positions for Sectoral Asset Management

Top funds holding Transmedics Group

BlackRock
FMR
Vanguard Portfolio Management
Vanguard Capital Management
Susquehanna International
Citadel Advisors
State Street Corporation
Nomura Asset Management International
Geode Capital Management
Toroso Investments
Hood River Capital Management
Morgan Stanley
Jane Street
Dimensional Fund Advisors
Braidwell

View all funds holding Transmedics Group